Cargando…
Cooperative behaviour and phenotype plasticity evolve during melanoma progression
A major challenge for managing melanoma is its tumour heterogeneity based on individual co‐existing melanoma cell phenotypes. These phenotypes display variable responses to standard therapies, and they drive individual steps of melanoma progression; hence, understanding their behaviour is imperative...
Autores principales: | Rowling, Emily J., Miskolczi, Zsofia, Nagaraju, Raghavendar, Wilcock, Daniel J., Wang, Ping, Telfer, Brian, Li, Yaoyong, Lasheras-Otero, Irene, Redondo-Muñoz, Marta, Sharrocks, Andrew D., Arozarena, Imanol, Wellbrock, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496243/ https://www.ncbi.nlm.nih.gov/pubmed/32145051 http://dx.doi.org/10.1111/pcmr.12873 |
Ejemplares similares
-
The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer
por: Wellbrock, Claudia, et al.
Publicado: (2016) -
Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy
por: Wellbrock, Claudia, et al.
Publicado: (2015) -
Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing
por: Miskolczi, Zsofia, et al.
Publicado: (2018) -
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
por: Ferguson, Jennifer, et al.
Publicado: (2012) -
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
por: Smith, Michael P., et al.
Publicado: (2016)